You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

3 Results
Drug
Other Name(s): Lupron Depot® , Eligard®
Updated
Apr 2026
Regimen
Cancer Type:
Genitourinary, 
Prostate
Intent: Neoadjuvant, Adjuvant, Palliative
Funding:
ODB - General Benefit
    leuprolide
Updated
Apr 2026
Guidelines and Advice
Status: Current
ID: GL 4-11
Version: 2
Updated
Mar 2026